| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0960-0760(90)90479-5 |
| P698 | PubMed publication ID | 2257234 |
| P50 | author | Erik W. Thompson | Q37829135 |
| Marc E Lippman | Q91264999 | ||
| P2093 | author name string | Dickson RB | |
| P2860 | cites work | A human cell line from a pleural effusion derived from a breast carcinoma | Q34207627 |
| P433 | issue | 3 | |
| P1104 | number of pages | 12 | |
| P304 | page(s) | 305-316 | |
| P577 | publication date | 1990-11-01 | |
| P1433 | published in | The Journal of Steroid Biochemistry and Molecular Biology | Q15708871 |
| P1476 | title | Regulation of proliferation, invasion and growth factor synthesis in breast cancer by steroids | |
| P478 | volume | 37 |
| Q41111222 | Activation of fibroblast growth factor 8 gene expression in human embryonal carcinoma cells |
| Q34324837 | Aromatase inhibitors--mechanisms for non-steroidal inhibitors |
| Q53573050 | Breast tumours following combined hormone replacement therapy express favourable prognostic factors. |
| Q43750590 | Chemical synthesis of 16beta-propylaminoacyl derivatives of estradiol and their inhibitory potency on type 1 17beta-hydroxysteroid dehydrogenase and binding affinity on steroid receptors. |
| Q37214702 | Cloning and characterization of an androgen-induced growth factor essential for the androgen-dependent growth of mouse mammary carcinoma cells |
| Q41645493 | Effect of estrogen and antiestrogens on cell proliferation and synthesis of secreted proteins in the human breast cancer cell line MCF-7 and a tamoxifen resistant variant subline, AL-1. |
| Q43557520 | Effect of highly bioaccumulated polychlorinated biphenyl congeners on estrogen and androgen receptor activity |
| Q34908885 | Effects of celecoxib and ly117018 combination on human breast cancer cells in vitro |
| Q43577795 | Estrogen and antiestrogen actions on transforming growth factorbeta (TGFbeta) in normal human breast epithelial (HBE) cells |
| Q34640715 | Examination of the estrogenicity of 2,4,6,2',6'-pentachlorobiphenyl (PCB 104), its hydroxylated metabolite 2,4,6,2',6'-pentachloro-4-biphenylol (HO-PCB 104), and a further chlorinated derivative, 2,4,6,2',4',6'-hexachlorobiphenyl (PCB 155). |
| Q40942364 | Hormonal control of growth factor receptor expression. |
| Q34565505 | Hormone/growth factor interactions mediating epithelial/stromal communication in mammary gland development and carcinogenesis |
| Q28300809 | Human androgen-induced growth factor in prostate and breast cancer cells: its molecular cloning and growth properties |
| Q36820050 | Identification of histone H2A.X as a growth factor secreted by an androgen-independent subline of mouse mammary carcinoma cells |
| Q60723256 | Induction of aromatase in stromal vascular cells from human breast adipose tissue depends on cortisol and growth factors |
| Q34826618 | Overweight, obesity, and cancer risk |
| Q37608402 | Preventive oncology in the postmenopausal woman. |
| Q42439883 | RU486 is a potent inhibitor of aromatase induction in human breast adipose tissue stromal cells. |
| Q36081748 | Relationship between tamoxifen-induced transforming growth factor beta 1 expression, cytostasis and apoptosis in human breast cancer cells |
| Q41631158 | Sex and the developing brain: suppression of neuronal estrogen sensitivity by developmental androgen exposure |
| Q33339120 | Solving the puzzle of hormone-dependent breast cancer |
| Q34669361 | The complexities of obesity and diabetes with the development and progression of pancreatic cancer |
| Q34238238 | The role of hormone replacement therapy in women with a previous diagnosis of breast cancer and a review of possible alternatives |
| Q36796680 | The use of steroid sulfatase inhibitors as a novel therapeutic strategy against hormone-dependent endometrial cancer |
Search more.